Regular ArticleApoptosis Rate Can Be Accelerated or Decelerated by Overexpression or Reduction of the Level of Elongation Factor-1α☆
References (27)
Trends Biochem. Sci.
(1995)- et al.
Biochem. Biophys. Res. Commun.
(1995) - et al.
Biochem. Biophys. Res. Commun.
(1993) - et al.
Exp. Cell Res.
(1994) - et al.
J. Biol. Chem.
(1990) - et al.
J. Biol. Chem.
(1993) - et al.
J. Biol. Chem.
(1994) - et al.
J. Biol. Chem.
(1995) Genes Dev.
(1996)- et al.
EMBO J.
(1995)
Microbiol. Rev.
Cellular Aging and Cell Death
EMBO J.
Cited by (109)
Elongation factor 1A1 regulates metabolic substrate preference in mammalian cells
2024, Journal of Biological ChemistryNatural products as drugs and tools for influencing core processes of eukaryotic mRNA translation
2021, Pharmacological ResearchDifferences in proteomic profile between two haemocyte types, granulocytes and hyalinocytes, of the flat oyster Ostrea edulis
2020, Fish and Shellfish ImmunologyNovel nannocystin A analogues as anticancer therapeutics: Synthesis, biological evaluations and structure–activity relationship studies
2019, European Journal of Medicinal ChemistryCitation Excerpt :Its antiproliferative activities probably resulted from the inhibition of eukaryotic translation elongation factor 1-α 1 (eEF1A1), which regulates the ribosomal protein synthesis and involves in cytoskeletal organization and other physiological activities [7,8]. In addition, eEF1A1 is associated with the development and progression of various human cancers [9,10] and has thus been proposed as a target for anticancer therapy [11]. However, no drug based on this target has been successfully marketed.
Identification of vitamin D<inf>3</inf> target genes in human breast cancer tissue
2016, Journal of Steroid Biochemistry and Molecular Biology
- ☆
HolbrookMartinLochsin
- 1
To whom correspondence and reprint requests should be addressed at Lady Davis Institute for Medical Research, Sir Mortimer B. Davis Jewish General Hospital, 3755, Chemin de la Côte Ste.-Catherine, Montréal, Québec, Canada H3T 1E2. Fax: (514) 340-8295.